Diagnostic kit maker Inverness Medical Innovations saw revenues climb in its fiscal fourth quarter but was unable to prevent net income from falling. Sales grew 26% to $546.2m during this period, receiving a boost from a higher uptake of influenza diagnostics, particularly in North ...
Please Login to read the full article.
